Medplus Health Services Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,864Cr
- +23.4% YoY
- +3.2% QoQ
- Net profit
- ₹64Cr
- +25.5% YoY
- +10.3% QoQ
- Margin
- 9%
- 0 pp YoY
- 0 pp QoQ
The short version
MedPlus aims to continue a balanced growth approach, focusing on both branded and private label products rather than aggressive private label expansion alone. The company expects to maintain or improve gross margins, driven by increasing private label share.
From Medplus Health Services Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- MedPlus aims to continue a balanced growth approach, focusing on both branded and private label products rather than aggressive private label expansion alone.
- The company expects to add approximately 800 new stores in FY27, including both company-owned and franchisee stores, indicating continued network expansion.
- Same-store sales growth (SSSG) target remains at an annualized rate of 9% to 10% over the next year.
- Private label growth guidance remains intact, aiming for a 20-30 basis points increase every quarter in private label share.
2 more points from Medplus Health Services Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- MedPlus plans to upgrade or modernize at least 600+ existing stores within the current year to accommodate more products, optimizing space and introducing smarter shelving/rack systems including pharma and non-pharma segmentation. (Page 16)
- Expansion through franchisee model is ongoing, with approximately 310 franchisee stores added recently, supporting faster network growth alongside company-owned store expansion. (Page 5)
- The company expects to continue store additions (around 800 stores next year), split between owned and franchisee stores, with more detailed splits to be shared in the future. (Page 5)
2 more points from Medplus Health Services Ltd's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Medplus Health Services Ltd said on order book & pipeline — free account, 30 seconds.
Medplus Health Services Ltd — Quarterly revenue & net profit
Medplus Health Services Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,864 | 1,510 | +23.4% | 1,806 | +3.2% |
| Operating profit (EBITDA) | 169 | 136 | +24.3% | 159 | +6.3% |
| Operating margin | 9% | 9% | 0 pp | 9% | 0 pp |
| Profit before tax | 80 | 61 | +31.1% | 73 | +9.6% |
| Net profit (PAT) | 64 | 51 | +25.5% | 58 | +10.3% |
| EPS (₹) | 5.33 | 4.29 | +24.2% | 4.82 | +10.6% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.0K Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Medplus Health's management said in earlier quarters
Others in Retailing this season
- Intrasoft Technologies (Q4 FY26)
Revenue from operations for the quarter ended Mar-26: ₹13,604.74 lakhs . Key investor presentation takeaways from Intrasoft Technologies's Q4 FY26 investor pres
- Brand Concepts (Q4 FY26)
Q4 FY26 Revenue from Operations: INR 90.42 Cr., up 25.0% YoY (Page 11) . Key investor presentation takeaways from Brand Concepts Ltd's Q4 FY26 investor presenta
- Womancart (Q4 FY26)
Revenue for H2FY26: ₹8,388.9 Lakhs, up 125.8% YoY (Page 10, 8) . Key investor presentation takeaways from Womancart's Q4 FY26 investor presentation — and how it
- Avenue Supermarts (Q4 FY26)
FY22: ₹30,353 Cr . Key investor presentation takeaways from Avenue Supermarts's Q4 FY26 investor presentation — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Medplus Health Services Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Medplus Health Services Ltd Q4 FY26 results?
MedPlus aims to continue a balanced growth approach, focusing on both branded and private label products rather than aggressive private label expansion alone. The company expects to maintain or improve gross margins, driven by increasing private label share.
What is Medplus Health Services Ltd share price analysis?
Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medplus Health Services Ltd planning capital expenditure?
MedPlus plans to upgrade or modernize at least 600+ existing stores within the current year to accommodate more products, optimizing space and introducing smarter shelving/rack systems including pharma and non-pharma segmentation.
Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
